The advances in the treatment of chronic myeloid leukemia (CML) during the last years were also accompanied by the development of evading strategies by tumor cells, resulting in chemotherapy resistance in some patients. Patented organopalladium compounds derived from the reaction of N, N-dimethyl-1-phenethylamine (dmpa) with [1,2-ethanebis(diphenylphosphine)] (dppe) exhibited a potent antitumor activity in vivo and in vitro in melanoma cells. We showed here that the cyclopalladated derivative [Pd-2(R(+))C-2, N-dmpa)(2)(mu-dppe) Cl-2], named compound 7b, was highly effective to promote cell death in the K562 human leukemia cells and its mechanisms of action were investigated. It was shown that compound 7b was able to promote exclusively apop...
The new glutathione S-transferase inhibitor 6-(7-nitro-2,1,3-benzoxadiazol- 4-ylthio)hexanol (NBDHEX...
The new glutathione S-transferase inhibitor 6-(7-nitro-2,1,3-benzoxadiazol- 4-ylthio)hexanol (NBDHEX...
The majority of chronic myeloid leukemia (CML) patients can be treated with and respond to imatinib ...
Abstract Background Systemic therapy for cancer metastatic lesions is difficult and generally render...
Background: Systemic therapy for cancer metastatic lesions is difficult and generally renders a poor...
In our study we found that pyrrolo[1,2‐b][1,2,5]benzothiadiazepines (PBTDs) mediated apoptosis in pr...
Adult T-cell leukemia/lymphoma (ATLL) is a highly aggressive disease that occurs in individuals infe...
Adult T-cell leukemia/lymphoma (ATLL) is a highly aggressive disease that occurs in individuals infe...
Adult T-cell leukemia/lymphoma (ATLL) is a highly aggressive disease that occurs in individuals infe...
Pyrrolo[1,2-b][1,2,5]benzothiadiazepine 5,5-dioxides (PBTDs) induced apoptosis in human BCR-ABL-expr...
Leukemia, the malignancy of the hematopoietic system accounts for 10% of cancer cases with poor ove...
[Pd(MSDT)Cl](n) palladium, chloro[methyl N-(dithiocarboxy-kS,kS')-N-methylglycinate], and [Pd(MSDT) ...
AbstractAimsWe evaluated biological activity in leukemia cells lines of R and S enantiomers of tert-...
We report that chlorogenic acid (Chl) induces apoptosis of several Bcr-Abl-positive chronic myelogen...
The new glutathione S-transferase inhibitor 6-(7-nitro-2,1,3-benzoxadiazol- 4-ylthio)hexanol (NBDHEX...
The new glutathione S-transferase inhibitor 6-(7-nitro-2,1,3-benzoxadiazol- 4-ylthio)hexanol (NBDHEX...
The new glutathione S-transferase inhibitor 6-(7-nitro-2,1,3-benzoxadiazol- 4-ylthio)hexanol (NBDHEX...
The majority of chronic myeloid leukemia (CML) patients can be treated with and respond to imatinib ...
Abstract Background Systemic therapy for cancer metastatic lesions is difficult and generally render...
Background: Systemic therapy for cancer metastatic lesions is difficult and generally renders a poor...
In our study we found that pyrrolo[1,2‐b][1,2,5]benzothiadiazepines (PBTDs) mediated apoptosis in pr...
Adult T-cell leukemia/lymphoma (ATLL) is a highly aggressive disease that occurs in individuals infe...
Adult T-cell leukemia/lymphoma (ATLL) is a highly aggressive disease that occurs in individuals infe...
Adult T-cell leukemia/lymphoma (ATLL) is a highly aggressive disease that occurs in individuals infe...
Pyrrolo[1,2-b][1,2,5]benzothiadiazepine 5,5-dioxides (PBTDs) induced apoptosis in human BCR-ABL-expr...
Leukemia, the malignancy of the hematopoietic system accounts for 10% of cancer cases with poor ove...
[Pd(MSDT)Cl](n) palladium, chloro[methyl N-(dithiocarboxy-kS,kS')-N-methylglycinate], and [Pd(MSDT) ...
AbstractAimsWe evaluated biological activity in leukemia cells lines of R and S enantiomers of tert-...
We report that chlorogenic acid (Chl) induces apoptosis of several Bcr-Abl-positive chronic myelogen...
The new glutathione S-transferase inhibitor 6-(7-nitro-2,1,3-benzoxadiazol- 4-ylthio)hexanol (NBDHEX...
The new glutathione S-transferase inhibitor 6-(7-nitro-2,1,3-benzoxadiazol- 4-ylthio)hexanol (NBDHEX...
The new glutathione S-transferase inhibitor 6-(7-nitro-2,1,3-benzoxadiazol- 4-ylthio)hexanol (NBDHEX...
The majority of chronic myeloid leukemia (CML) patients can be treated with and respond to imatinib ...